All subjects underwent lactulose/methane breath test (LBT) to assess SIBO before and one month after the treatment with Rifaximin 600 mg daily. All IBS pts filled out a Visual Analogic Scale (VAS ...

Rifaximin is a minimally absorbed antibiotic that is FDA-approved for treatment of travelers' diarrhea and prevention of hepatic encephalopathy. The primary endpoint (patient-reported "adequate ...

At present, chemoprophylaxis with minimally absorbed rifaximin is recommended for travelers who are not likely to be careful about dietary restrictions and for those who are concerned about the ...